OVERVIEW

Patients with radioactive iodine-refractory thyroid cancer (RAIR-DTC) have poor prognoses and, until recently, there were no effective targeted systemic therapies available for RAIR-DTC.

Join Endocrine Society staff and other endocrine training program directors and coordinators as we get to know the new Fellows Training Series!

Subscribe to RSS - Webinar